Poloxamer 407, an FDA-approved polymer whose properties can be reversed by heating, is injected at the site where the blood vessels are to be joined, and the area is heated.
The Poloxamer 407 becomes elastic and solid when heated, causing openings of a severed blood vessel to become distended so that surgeons can precisely join the openings together with Dermabond, a commonly used surgical sealant.
Related Articles on Medical Innovations:
CTQ Solutions Announces 2011 Apex Quality Award Winners for Healthcare Excellence
New Gas Connector Reduces Risk of Misconnection
New Skin Patch Contains Diagnostics Devices
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
